Helix Biopharma Corp
TSX:HBP

Watchlist Manager
Helix Biopharma Corp Logo
Helix Biopharma Corp
TSX:HBP
Watchlist
Price: 2.18 CAD 3.32% Market Closed
Market Cap: 166.5m CAD

Net Margin
Helix Biopharma Corp

0%
Current
0%
Average
-6.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-5.2m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Helix Biopharma Corp
Glance View

Market Cap
161.7m CAD
Industry
Biotechnology

Helix BioPharma Corp. is an immuno-oncology company, which develops products for the treatment and prevention of cancer. The company is headquartered in Richmond Hill, Ontario and currently employs 10 full-time employees. Helix’s proprietary technological platforms include DOS47, V-DOS47 and L-DOS47. The DOS47 is an oncology platform that offers a debilitation and destruction of cancer cells by modulating the tumor microenvironment. DOS47 is designed to stimulate an increase in the pH of the microenvironment surrounding the cancerous cells, effectively reversing the acidic extracellular conditions that are believed to act to defend the tumor. L-DOS47 is an antibody protein conjugate where the urease component enzymatically converts naturally occurring urea to ammonia. The L-DOS47 drug molecule includes a specialized camelid-derived single domain antibody. V-DOS47 targets the vascular endothelial growth factor two receptor (VEGFR2) and can be used in several types of solid tumors.

HBP Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-5.2m
/
Revenue
0
What is the Net Margin of Helix Biopharma Corp?

Based on Helix Biopharma Corp's most recent financial statements, the company has Net Margin of 0%.

Back to Top